PubMed Health⌕ Search

PubMed · 820726

Serum urea analysis using the Beckman BUN Analyzer.

Abstract

A new instrument, the Beckman BUN Analyzer, has been produced for the estimation of urea in microvolume (0-01 ml) of serum or plasma. It requires only a simple two-point calibration for standardization and is suitable for a range of urea levels from zero to 70 mmol/l. The test procedure is simple. After the initial calibration the test sample is injected into the testing chamber and a digital result of the urea concentration is displayed. Serum urea measurements made by this method compared well with those obtained by the Technicon AutoAnalyzer method over the entire working range. The within-batch coefficient of variation of the method is 5-5%, and less at urea levels of 11 to 44 mmol/l. The between-batch coefficient of variation of the method is 6-9%, and less at urea concentrations of 10 to 47 mmol/l. The BUN Aanalyzer method is a quick and reliable alternative to conventional laboratory methods for serum or plasma urea estimation and is especially useful for urgent investigations of both adult and paediatric patients in the hospital wards and at the outpatient clinics.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K S Chua, I K Tan. 1976. Serum urea analysis using the Beckman BUN Analyzer.. https://doi.org/10.1136/jcp.29.6.517

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Detection of Delta9-tetrahydrocannabinolic acid A in human urine and blood serum by LC-MS/MS.

Delta9-tetrahydrocannabinolic acid A (Delta9-THCA-A) is the precursor of Delta9-tetrahydrocannabinol (Delta9-THC) in hemp plants. During smoking, the non-psychoactive Delta9-THCA-A is converted to Delta9-THC, the main psychoactive component of marihuana and hashish. Although the decarboxylation of Delta9-THCA-A to Delta9-THC was assumed to be complete--which means that no Delta9-THCA-A should be detectable in urine and blood serum of cannabis consumers--we found Delta9-THCA-A in the urine and blood serum samples collected from police controls of drivers suspected for driving under the influence of drugs (DUID). For LC-MS/MS analysis, urine and blood serum samples were prepared by solid-phase extraction. Analysis was performed with a phenylhexyl column using gradient elution with acetonitrile. For detection of Delta9-THCA-A, the mass spectrometer (MS) (SCIEX API 365 triple-quadrupole MS with TurboIonSpray source) was operated in the multiple reaction monitoring (MRM) mode using the following transitions: m/z357 --> 313, m/z357 --> 245 and m/z357 --> 191. Delta9-THCA-A could be detected in the urine and blood serum samples of several cannabis consumers in concentrations of up to 10.8 ng/ml in urine and 14.8 ng/ml in serum. The concentration of Delta9-THCA-A was below the Delta9-THC concentration in most serum samples, resulting in molar ratios of Delta9-THCA-A/Delta9-THC of approximately 5.0-18.6%. Only in one case, where a short elapsed time between the last intake and blood sampling is assumed, the molar ratio was 18.6% in the serum. This indicates differences in elimination kinetics, which need to be investigated in detail.

Blood Chemical Analysis↗